![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/zeiss-share-stage_v2.jpg/_jcr_content/renditions/original.image_file.100.33.0,307,2000,974.file/zeiss-share-stage_v2.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/zeiss-share-stage_v2.jpg/_jcr_content/renditions/original.image_file.360.120.0,307,2000,974.file/zeiss-share-stage_v2.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/zeiss-share-stage_v2.jpg/_jcr_content/renditions/original.image_file.768.256.0,307,2000,974.file/zeiss-share-stage_v2.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/zeiss-share-stage_v2.jpg/_jcr_content/renditions/original.image_file.1024.341.0,307,2000,974.file/zeiss-share-stage_v2.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/zeiss-share-stage_v2.jpg/_jcr_content/renditions/original.image_file.1280.427.0,307,2000,974.file/zeiss-share-stage_v2.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/zeiss-share-stage_v2.jpg/_jcr_content/renditions/original.image_file.1440.480.0,307,2000,974.file/zeiss-share-stage_v2.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/zeiss-share-stage_v2.jpg/_jcr_content/renditions/original.image_file.1920.640.0,307,2000,974.file/zeiss-share-stage_v2.jpg"})
Carl Zeiss Meditec AG share
Investing in Carl Zeiss Meditec AG is an investment in the future of the health sector. We drive the development of leading-edge technology and make it available for applications in the field of: ophthalmology, neurosurgery, ENT surgery, dental applications and systems for intraoperative radiotherapy.
Quotes, Charts & Orderbook
Security Identification Numbers
|
Stock exchange abbreviation |
AFX |
|---|---|
|
ISIN |
DE0005313704 |
|
Reuters Identification Code (RIC) |
AFXG.F (exchange floor) |
|
Bloomberg |
AFX GR |
Key Facts at a Glance
-
ISIN
DE0005313704
Trading Segment
Prime Standard
Designated Sponsors
ODDO BHF Corporates & Markets AG
Paying Agent
Commerzbank AG
Share Capital
€89,440,570.00
Admitted Capital
€89,440,570.00
Category and Nominal Value
No-par value bearer shares at a nominal value of €1.00 per share
Stock Markets
Deutsche Börse in Frankfurt (XETRA and exchange floor, “Parkett”)
Regional stock exchanges in Berlin, Bremen, Düsseldorf, Hamburg, Munich and StuttgartCapital Measures
23-Mar-2017:
Increase of the share capital of €89,309,610.00
against cash contribution by €8,130,960.00 (approx. 10%) to
€89,440,570.00; subscription rights of shareholders were excluded.26-Oct-2006:
Increase of the share capital of €32,523,844.00 (divided into 32,523,844 no-par value shares) by €48,785,766.00 to €81,309,610.00 (divided into 81,309,610 no-par value shares); capital increase with subscription rights and against contributions in kind and cash contributions.10-May-2005:
Increase of the share capital of €29,682,182.00 against cash contribution by €2,841,662.00 (approx. 10%) to €32,523844.00; subscription rights of shareholders were excluded.01-Feb-2005:
Increase of the share capital of €28,416,628.00 against contribution in kind by €1,265,553.00
(4.45%) to €29,682,182.00; subscription rights of shareholders were excluded;
capital increase was part of the acquisition of the majority holding in IOLTech S.A.18-Sep-2003:
Increase of the share capital of €25,833,300.00 against cash contribution by €2,583,329.00
(10%) to €28,416,629.00; subscription rights of shareholders were excluded. -
-
2023/242022/232021/222020/212019/202018/19
XETRA
Year-end price (EUR)1
71.15
82.82
107.45
166.05
108.00
104.60
Year high (EUR)2
123.75
142.75
191.05
199.05
121.40
108.70
Year low (EUR)2
54.60
78.66
101.75
105.14
69.70
61.00
Year average (EUR)
86.56
115.18
141.67
142.65
98.18
81.80
Daily order book turnover (XETRA) in fiscal year
EUR
15,367,421
14,817,336
16,090,137
13,264,306
Shares
155,647
104,284
109,627
105,938
167,107
162,154
Number of shares as of 30 September
(million shares)89.4
89.4
89.4
89.4
89.4
89.4
Market capitalization as of 30 September
(million EUR)5,075.8
7,511.2
9,610.40
14,851.60
9,659.6
9,355.5
Earnings per share (EUR)
2.01
3.25
3.29
2.64
1.37
1.79
Dividend per share (EUR)
0.603
1.10
1.10
0.90
0.5
0.65
Dividend yield (%)4
0.8
1.3
1.0
0.5
0.5
0.7
-
Bank/Analyst
Current Rating
Date
Price Target
ALPHAVALUE
Anas PatelBuy
06-08-2024
€97.40
Bank of America
Julien OuaddourHold
18-07-2024
€70.00
Berenberg Bank
Sam EnglandHold
06-12-2024
€66.00
Deutsche Bank AG
Falko FriedrichsHold
09-08-2024
€66.00
DZ Bank
Sven KürtenHold
03-07-2024
€68.00
EQUI.TS GmbH
Thomas SchießleHold
18-07-2024
€105.00
Equita
Davide MarchesinHold
08-08-2024
€70.00
Goldman Sachs
Richard FeltonSell
23-09-2024
€54.00
Hauck & Aufhäuser
Alexander GalitsaBuy
23-09-2024
€90.00
HSBC
Sezgi OezenerHold
20-06-2024
€74.00
JPM
Anchal VermaUnderweight
03-12-2024
€45.00
Kepler Cheuvreux
Oliver ReinbergHold
10-09-2024
€62.00
LBBW
Volker StollBuy
17-06-2024
€92.00
Metzler
Alexander NeubergerBuy
17-09-2024
€104.00
mwb research
Harald HofBuy
07-08-2024
€78.00
ODDO BHF
Oliver MetzgerNeutral
05-08-2024
€70.00
RBC
Jack Reynolds-ClarkOutperform
06-12-2024
€85.00
Stifel
Dylan Van HaaftenSell
27-09-2024
€60.00
UBS
Graham DoyleNeutral
08-08-2024
€71.00
Please note: Banks and securities firms use different terms for their equity ratings. The information contained in the table is based on publicly available sources that we consider reliable but for which we do not assume any liability.
In particular, we do not guarantee that the information is complete, accurate or up-to-date. All ratings are based on opinions given by the analysts in question. These do not necessarily reflect the opinion of Carl Zeiss Meditec AG. The assessments may change at any time without prior notice. Exemption from liability applies to Carl Zeiss Meditec AG; it does not refer to the correct rendering of the information based on external sources, in particular public sources.
Analyst assessments relating to Carl Zeiss Meditec AG shares are only revised each quarter and are therefore not continually updated.
-
ZEISS Shareholder Structure
Carl Zeiss Meditec AG's subscribed capital is composed of 89,440,570 ordinary shares, each with a theoretical par value of €1 per share. The ZEISS Group holds around 59% of the shares. According to our knowledge, the remaining 41% are in free float.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/annual_report_meditec_2023-24_dividende_en.jpg/_jcr_content/renditions/original.image_file.100.25.10,0,1542,383.file/annual_report_meditec_2023-24_dividende_en.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/annual_report_meditec_2023-24_dividende_en.jpg/_jcr_content/renditions/original.image_file.360.90.10,0,1542,383.file/annual_report_meditec_2023-24_dividende_en.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/annual_report_meditec_2023-24_dividende_en.jpg/_jcr_content/renditions/original.image_file.768.192.10,0,1542,383.file/annual_report_meditec_2023-24_dividende_en.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/annual_report_meditec_2023-24_dividende_en.jpg/_jcr_content/renditions/original.image_file.1024.256.10,0,1542,383.file/annual_report_meditec_2023-24_dividende_en.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/annual_report_meditec_2023-24_dividende_en.jpg/_jcr_content/renditions/original.image_file.1280.320.10,0,1542,383.file/annual_report_meditec_2023-24_dividende_en.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/annual_report_meditec_2023-24_dividende_en.jpg/_jcr_content/renditions/original.image_file.1440.360.10,0,1542,383.file/annual_report_meditec_2023-24_dividende_en.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/annual_report_meditec_2023-24_dividende_en.jpg/_jcr_content/renditions/original.image_file.1532.383.10,0,1542,383.file/annual_report_meditec_2023-24_dividende_en.jpg"})
![ZEISS Shareholder Structure]({"xsmall":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/grafik_16_9.jpg/_jcr_content/renditions/original.image_file.100.56.1,0,1032,580.file/grafik_16_9.jpg","small":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/grafik_16_9.jpg/_jcr_content/renditions/original.image_file.360.203.1,0,1032,580.file/grafik_16_9.jpg","medium":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/grafik_16_9.jpg/_jcr_content/renditions/original.image_file.768.432.1,0,1032,580.file/grafik_16_9.jpg","large":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/grafik_16_9.jpg/_jcr_content/renditions/original.image_file.1024.576.1,0,1032,580.file/grafik_16_9.jpg","xlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/grafik_16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/grafik_16_9.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/grafik_16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/grafik_16_9.jpg","max":"https://www.zeiss.com/content/dam/med-ag/investor-relations/share/grafik_16_9.jpg/_jcr_content/renditions/original.image_file.1031.580.1,0,1032,580.file/grafik_16_9.jpg"} "ZEISS Shareholder Structure")
Fact Sheet
Carl Zeiss Meditec AG
Request investor information
-
1
30 September.
-
2
XETRA closing price.
-
3
Amounts suggested by the Supervisory Board and the Executive Board of the Carl Zeiss Meditec AG.
-
4
Untill FY 2016/17 ratio of dividend per share to opening price for the respective fiscal year, from FY 2017/18 ratio of dividend per share to closing rate on 30 September.